Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuropharmacology

• Publication date

  2013-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuropharm.2013.05.031PMID 23954676PMCID PMC3865020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm.

  2013influential reference
• Olanzapine Sensitization and Clozapine Tolerance: From Adolescence to Adulthood in the Conditioned Avoidance Response Model

  2013influential reference
• Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

  2013influential reference
• The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania

  2013cited by this paper
• Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test–retest interval

  2012influential reference
• Drug–drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia

  2012cited by this paper
• Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.

  2012influential reference
• Involvement of 5‐HT2A receptor and α2‐adrenoceptor blockade in the asenapine‐induced elevation of prefrontal cortical monoamine outflow

  2012cited by this paper
• Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine

  2012influential reference
• Clozapine: balancing safety with superior antipsychotic efficacy.

  2012cited by this paper
• Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity.

  2012cited by this paper
• Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors

  2012influential reference
• Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.

  2012cited by this paper
• Understanding and assessing adverse drug reactions.

  2011cited by this paper
• Update on newer antipsychotic drugs.

  2011cited by this paper
• Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

  2011cited by this paper
• Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism

  2011influential reference
• Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism

  2010influential reference
• Iptakalim: a potential antipsychotic drug with novel mechanisms?

  2010influential reference
• Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning

  2010influential reference
• Asenapine induces differential regional effects on serotonin receptor subtypes

  2010cited by this paper
• Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.

  2010cited by this paper
• Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.

  2010influential reference
• Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

  2009influential reference
• An investigation of the behavioral mechanisms of antipsychotic action using a drug–drug conditioning paradigm

  2009cited by this paper
• Asenapine

  2009cited by this paper
• Asenapine effects in animal models of psychosis and cognitive function

  2009influential reference
• Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus

  2009cited by this paper
• Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.

  2009influential reference
• Monographs: Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania.

  2009cited by this paper
• Differential regional and dose-related effects of asenapine on dopamine receptor subtypes

  2008cited by this paper
• Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia

  2008influential reference
• Asenapine Increases Dopamine, Norepinephrine, and Acetylcholine Efflux in the Rat Medial Prefrontal Cortex and Hippocampus

  2008influential reference
• Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions

  2008influential reference
• Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.

  2008cited by this paper
• Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic

  2007cited by this paper
• Time Course of the Antipsychotic Effect and the Underlying Behavioral Mechanisms

  2007cited by this paper
• Repeated antipsychotic drug exposurein developing rats: Dopamine receptor effects

  2006cited by this paper
• Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.

  2005cited by this paper
• Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

  2003cited by this paper
• Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.

  2001cited by this paper
• Region‐specific induction of ΔFosB by repeated administration of typical versus atypical antipsychotic drugs

  1999cited by this paper
• Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity.

  1999cited by this paper
• Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5‐HT2A sites for PCP‐induced locomotion in the rat

  1999influential reference
• Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

  1997influential reference
• Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.

  1995cited by this paper
• Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.

  1995cited by this paper

• Differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an MK-801-induced mouse model of schizophrenia.

  2024cites this paper
• Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood.

  2024cites this paper
• Maternal immune activation and repeated maternal separation alter offspring conditioned avoidance response learning and antipsychotic response in male rats.

  2021cites this paper
• Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.

  2020cites this paper
• Reinforcement attenuation as a behavioral technique to suppress conditioned avoidance response in rats: A comparative study with olanzapine

  2018cites this paper
• A drug–drug conditioning paradigm reveals multiple antipsychotic–nicotine interactions

  2017cites this paper
• Time‐dependent sensitization of antipsychotic effect in adolescent male and female rats

  2017cites this paper
• ASENAPINE MALEATE LOADED SOLID LIPID NANOPARTICLES FOR ORAL DELIVERY

  2017cites this paper
• Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms

  2016influential citation
• Impact of repeated asenapine treatment on FosB/ΔFosB expression in the forebrain structures under normal conditions and mild stress preconditioning in the rat.

  2016cites this paper
• Repeated administration of 5‐hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity

  2016cites this paper
• Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function

  2015cites this paper
• Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.

  2015influential citation
• Effects of central activation of serotonin 5-HT2A/2C or dopamine D2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test

  2015cites this paper
• Effects of maternal immune activation and repeated maternal separation on postpartum behaviors in the female rat offspring

  2015cites this paper
• Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.

  2015cites this paper
• Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.

  2014cites this paper
• Asenapine sensitization from adolescence to adulthood and its potential molecular basis.

  2014cites this paper
• Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.

  2014cites this paper
• Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

  2013cites this paper
• Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?

  2013cites this paper